医学
药品审批
梅德林
肿瘤科
重症监护医学
内科学
药理学
政治学
法学
药品
作者
Lola A. Fashoyin‐Aje,Gautam U. Mehta,Julia A. Beaver,Richard Pazdur
摘要
To address ongoing concerns about the implementation of the FDA's Accelerated Approval pathway in oncology, a comprehensive strategy is needed — one that equally emphasizes "on-ramp" and "off-ramp" considerations.
科研通智能强力驱动
Strongly Powered by AbleSci AI